Search Results - abhijit+kulkarni

1 Results Sort By:
Allosteric Probes for CB1 Cannabinoid Receptor
esponse. The enhancers of CB1 receptor activity have the potential to treat diseases such as depression, anxiety, multiple sclerosis, and pain. CB1 inhibitors can treat metabolic syndrome as well as drug and alcohol addiction. CB1 inhibitor drugs have been developed for the treatment of type 2 diabetes, weight loss, smoking cessation, and osteoporosis...
Published: 9/10/2024   |   Inventor(s): Ganeshsingh Thakur, Pushkar Kulkarni, Abhijit Kulkarni, Ritesh Tichkule
Keywords(s): Chemistry, Drug Discovery & Development, Health, Pharmaceutical Composition
Category(s): -Pharmaceutical Composition, -Health, -Chemistry, Technology Classifications > 1. Life Science > Therapeutics, Technology Classifications > 1. Life Science > Drug Discovery